Automera
News,Biotech / MedTech,Singapore
Automera secures $16M in Series A funding co-led by ALSP, ClavystBio
Automera, a new biotechnology company based in Singapore, has secured $16 million in Series A funding co-led by Accelerator Life Science Partners (ALSP) and ClavystBio. The funding also saw participation from Singapore-based global investor EDBI, Xora Innovation, and other undisclosed investors.
September 27, 2023
WGSN expands access of AI-powered platform to Asia
September 10, 2025
TM and Scicom form strategic partnership to deliver AI solutions
September 10, 2025
WGSN expands access of AI-powered platform to Asia
September 10, 2025
TM and Scicom form strategic partnership to deliver AI solutions
September 10, 2025